RTW INVESTMENTS, LP

Position in QURE — uniQure N.V.

CIK 1493215 NEW YORK, NY

Position in QURE

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$181,548,806

+$139,261,886 QoQ

Shares Held

3,941,572

+52.4% QoQ

Ownership

6.25%

of shares outstanding

% of Portfolio

1.55%

of 13F equity value

Holder Rank

of 255 holders

Holding Since

Mar 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

RTW INVESTMENTS, LP holds $9,530,420,260 across 63 Biotechnology names. QURE ranks #17 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,070,510,234
2	ARGX	Argenx SE	709,446	$658,202,715
3	PTCT	Ptc Therapeutics, Inc.	7,746,415	$631,875,071
4	PTGX	Protagonist Therapeutics, Inc	5,061,175	$620,398,831
5	CGON	CG Oncology, Inc.	8,514,590	$604,961,619
6	INSM	INSMED Inc	4,842,880	$516,347,865
7	TNGX	Tango Therapeutics, Inc.	13,900,620	$434,533,381
8	SYRE	Spyre Therapeutics, Inc.	4,251,996	$377,492,204

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$181,548,806	3,941,572	+52.4%	Shares	Sole	2026-08-14
2026-03-31	$42,286,920	2,586,356	-30.3%	Shares	Sole	2026-05-15
2025-12-31	$88,815,285	3,711,462	-16.1%	Shares	Sole	2026-02-17
2025-09-30	$258,285,382	4,424,968	-14.2%	Shares	Sole	2025-11-14
2025-06-30	$71,905,740	5,158,231	+20.9%	Shares	Sole	2025-08-14
2025-03-31	$45,213,536	4,265,428	+372.0%	Shares	Sole	2025-05-15
2024-12-31	$15,958,017	903,625	+8936.2%	Shares	Sole	2025-02-14
2024-09-30	$49,300	10,000	-93.7%	Shares	Sole	2024-11-14
2020-09-30	$5,836,781	158,479	+0.8%	Shares	Sole	2020-11-16
2020-06-30	$7,087,126	157,282	+0.8%	Shares	Sole	2020-08-14
2020-03-31	$7,405,806	156,076	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.